etomoxir has been researched along with Breast Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brglez, V; Lambeau, G; Payré, C; Petan, T; Pucer, A; Pungerčar, J | 1 |
Broom, OJ; Nordström, A; Stäubert, C | 1 |
Kuhajda, FP; McFadden, JM; Medghalchi, SM; Pinn, ML; Ronnett, GV; Simpson, PJ; Townsend, CA; Vadlamudi, A; Zhou, W | 1 |
Kuhajda, FP; Pinn, ML; Thupari, JN | 1 |
4 other study(ies) available for etomoxir and Breast Neoplasms
Article | Year |
---|---|
Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival.
Topics: AMP-Activated Protein Kinases; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; Enzyme Activation; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Group X Phospholipases A2; Humans; Hydrolysis; Lipid Metabolism; Oleic Acids; Organelles; Oxidation-Reduction; Phosphatidylcholines; Proto-Oncogene Proteins c-akt | 2013 |
Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism.
Topics: Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Lipid Metabolism; Oxidation-Reduction; Perhexiline; Receptors, G-Protein-Coupled; Receptors, Nicotinic; RNA Interference; RNA, Messenger; Signal Transduction; Tandem Mass Spectrometry; Time Factors; Transfection; Tumor Cells, Cultured | 2015 |
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Topics: 4-Butyrolactone; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Division; Cell Line, Tumor; Drug Interactions; Epoxy Compounds; Fatty Acid Synthases; Furans; Humans; Membrane Lipids; Phospholipids; S Phase | 2003 |
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Topics: Acetyl-CoA Carboxylase; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Survival; Cerulenin; Enzyme Inhibitors; Epoxy Compounds; Fatty Acid Synthases; Fatty Acids; Female; Furans; Humans; Hypolipidemic Agents; Kinetics; Malonyl Coenzyme A; Models, Biological; Oxidation-Reduction; Tumor Cells, Cultured | 2001 |